tiprankstipranks
Patrys Limited (AU:PAB)
ASX:PAB

Patrys Limited (PAB) Share Price & Analysis

1 Followers

PAB Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week Range<AU$0.01 - AU$0.01
Previous CloseAU$0.01
Volume739.22K
Average Volume (3M)N/A
Market Cap
AU$13.37M
Enterprise ValueAU$3.55M
Total Cash (Recent Filing)AU$9.82M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)
Beta0.05
Aug 22, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,057,447,335
10 Day Avg. Volume4,690,686
30 Day Avg. VolumeN/A
Standard Deviation0.55
R-Squared0.00011
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

7.36%0.00%0.00%92.64%
7.36%
Insiders
0.00% Other Institutional Investors
92.64% Public Companies and
Individual Investors

PAB FAQ

What was Patrys Limited’s price range in the past 12 months?
Patrys Limited lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
    What is Patrys Limited’s market cap?
    Currently, no data Available
    When is Patrys Limited’s upcoming earnings report date?
    Patrys Limited’s upcoming earnings report date is Aug 22, 2024 which is in 29 days.
      How were Patrys Limited’s earnings last quarter?
      Patrys Limited released its earnings results on Feb 23, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
        Is Patrys Limited overvalued?
        According to Wall Street analysts Patrys Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Patrys Limited pay dividends?
          Patrys Limited does not currently pay dividends.
          What is Patrys Limited’s EPS estimate?
          Patrys Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Patrys Limited have?
          Patrys Limited has 2,057,447,300 shares outstanding.
            What happened to Patrys Limited’s price movement after its last earnings report?
            Patrys Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Patrys Limited?
              Currently, no hedge funds are holding shares in AU:PAB
              ---

              Company Description

              Patrys Limited

              Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 and PAT-DX1-NP, and PAT-LM1. Its lead technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody which penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Noxopharm Ltd.
              Vectus Biosystems Limited
              Patrys Limited
              Chimeric Therapeutics Ltd.
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis